TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside April 28, 2000